First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers

Conditions: Coronavirus Interventions: Biological: OVX033; Biological: Saline solution Sponsors: Osivax; Centre for the Evaluation of Vaccination H ôpital Cochin Assistance Publique - Hôpitaux de Paris (APHP) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials